0002108475-26-000001.txt : 20260202 0002108475-26-000001.hdr.sgml : 20260202 20260130205126 ACCESSION NUMBER: 0002108475-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260202 DATE AS OF CHANGE: 20260130 EFFECTIVENESS DATE: 20260202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Squarestart-Aletira Therapeutics QOZB SPV 1 LLC CENTRAL INDEX KEY: 0002108475 ORGANIZATION NAME: EIN: 394429985 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-572013 FILM NUMBER: 26585362 BUSINESS ADDRESS: STREET 1: 5000 THAYER CIRCLE STREET 2: STE C CITY: OAKLAND STATE: MD ZIP: 21550 BUSINESS PHONE: 5097682249 MAIL ADDRESS: STREET 1: 5000 THAYER CIRCLE STREET 2: STE C CITY: OAKLAND STATE: MD ZIP: 21550 D 1 primary_doc.xml X0708 D LIVE 0002108475 Squarestart-Aletira Therapeutics QOZB SPV 1 LLC 5000 THAYER CIRCLE STE C OAKLAND MD MARYLAND 21550 5097682249 MARYLAND None None Limited Liability Company true 2025 Square Start LLC 522 W Riverside Ave Ste N Spokane WA WASHINGTON 99201 Director Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2025-12-29 false true false 0 884615 884615 0 false 15 0 0 0 true Operational and management expenses paid separately. false Squarestart-Aletira Therapeutics QOZB SPV 1 LLC Jenny Dworzak Jenny Dworzak Manager, Square Start LLC, Manager Issuer 2026-01-30